Németh György - Perelman School of Medicine, Gedeon Richter Plc

基本信息

浏览量：27

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 162 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Transdiagnostic Global Impression - Psychopathology Scale (TGI-P): Initial Development of a Novel Transdiagnostic Tool for Assessing, Tracking, and Visualising Psychiatric Symptom Severity in Everyday Practice

Christoph U. Correll,Zsofia B. Dombi,Agota Barabassy,Gyorgy Nemeth, Thomas Brevig,Roger S. McIntyre

European Neuropsychopharmacology (2024): 31-39

引用0浏览0WOS引用

D3 Receptor-Targeted Cariprazine: Insights from Lab to Bedside

Ágota Barabássy,Zsófia Borbála Dombi,György Németh

International journal of molecular sciencesno. 11 (2024)

引用0浏览0WOS引用

Cariprazine’s Efficacy in Treating Depressive Symptoms – Pooled Data from Schizophrenia, Bipolar Depression and Major Depression Trials

R. S. McIntyre,R. Csehi,G. Nemeth

European psychiatryno. S1 (2023): S297-S298

引用0浏览0引用

The Improvement of Motor Symptoms in Huntington’s Disease During Cariprazine Treatment

Reka Csehi,Viktor Molnar,Mariann Fedor, Vivien Zsumbera, Agnes Palasti,Karoly Acsai,Zoltan Grosz,Gyorgy Nemeth,Maria Judit Molnar

Orphanet journal of rare diseasesno. 1 (2023): 375-375

引用0浏览0WOS引用

Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of Clinical Trial Data Vs. Real-World Evidence

E. Rancans,Z. B. Dombi,R. Csehi,G. Nemeth

European psychiatryno. S1 (2023): S641-S641

引用0浏览0引用

Time course of significantly greater improvement in global illness-severity with cariprazine versus risperidone in schizophrenia patients with predominant negative symptoms

C. Correll,R. Csehi,Z.B. Dombi,G. Németh

Neuroscience Applied (2023): 103035

引用0浏览0引用

Cariprazine in Female Schizophrenia Patients: Real-World Evidence from an Observational Study

E. Rancans,Z.B. Dombi,K. Acsai,G. Németh

Neuroscience Applied (2023): 103029

引用0浏览0引用

The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials

Peter Falkai,Zsófia B Dombi,Károly Acsai,Ágota Barabássy,Andrea Schmitt,György Németh

CNS Spectr（2023）

引用0浏览0WOS引用

Clinical Staging in Schizophrenia Spectrum Disorders

Zsófia Borbála Dombi,Ágota Barabássy,Barbara Sebe,István Laszlovszky,György Németh

Psychosis - Phenomenology, Psychopathology and Pathophysiology (2022)

引用0浏览0引用

What is the Minimum Clinically Important Change in Negative Symptoms of Schizophrenia? PANSS Based Post-hoc Analyses of a Phase III Clinical Trial

Pal Czobor,Barbara Sebe,Karoly Acsai,Agota Barabassy,Istvan Laszlovszky,Gyoergy Nemeth,Toshi A. Furukawa,Stefan Leucht

Frontiers in psychiatry（2022）

引用4浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn